News Feed Opinion Blog Posts Career Updates Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
August, 2025
August 2025
M T W T F S S
 123
45678910
11121314151617
18192021222324
25262728293031
Tom Powles: Perioperative durvalumab + ctDNA are changing the muscle invasive bladder cancer
Tom Powles/X
Jan 26, 2025, 12:10

Tom Powles: Perioperative durvalumab + ctDNA are changing the muscle invasive bladder cancer

Tom Powles, Professor at the University of London, shared on X:

“The muscle invasive bladder cancer session AUC3 discussed perioperative durvalumab + ctDNA are changing the disease. Also, pCR of >50% is expected with EVP. Bladder sparing approaches after EVP is likely to be the standard of care if this is the case. ”

Tom Powles: Perioperative durvalumab + ctDNA are changing the muscle invasive bladder cancer

cancer OncoDaily Oncology Tom Powles
Special Coverage
Voices
Aug 12, 2025, 11:59
Nikhil Vojjala: Eight Aspects of Oncology That Aren’t Taught in Training
Insight
Aug 12, 2025, 11:29
Daniel Flora: Joining Ride Cincinnati 2025 for Cancer Research
Voices
Aug 12, 2025, 11:19
AACR President Highlights the Critical Value of Medical Research
Insight
Aug 12, 2025, 11:14
Felipe Couñago: URONCOR 06-24 Trial Data
Science
Aug 12, 2025, 11:04
Yüksel Ürün: CTCs are Cancer’s Messengers in the Blood Rare, but Powerful
Voices
Aug 12, 2025, 11:03
Amy C. Moore Wished Yvonne Diaz a Happy Birthday
Science
Aug 12, 2025, 10:50
Off-the-Shelf Cancer Vaccine Elicits Strong Immune Response in Patients with Pancreatic and Colorectal Cancer
Voices
Aug 12, 2025, 10:34
The Efficacy of Immune Checkpoint Inhibitors in Melanoma Through a Gut Microbiota - Mirrors of Medicine
Societies
Aug 12, 2025, 10:33
How Science, Technology, and Access are Coming Together to Stop Cancer Before it Starts - NFCR
Science
Aug 12, 2025, 10:24
Myeloma Paper of the Day, August 12th, Suggested by Robert Orlowski
New Paper Alert
Aug 12, 2025, 10:24
New Paper Alert: Older Age Threshold for Oxaliplatin Benefit in Stage II–III Colorectal Cancer Identified
Career Updates
Aug 12, 2025, 10:23
Bruce Cozadd: 22 Incredible Years Leading Jazz Pharmaceuticals